Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Stéphanie Esselin"'
Autor:
Frédéric Vigant, Betsy Jullienne, Paule Opolon, Stéphanie Esselin, Karim Benihoud, Emmanuelle Vigne, Michel Perricaudet, Thierry Tordjmann, Elisabeth Connault, Delphyne Descamps
Publikováno v:
Molecular Therapy
Molecular Therapy, 2008, 16 (8), pp.1474-80. ⟨10.1038/mt.2008.132⟩
Molecular Therapy, Cell Press, 2008, 16 (8), pp.1474-80. ⟨10.1038/mt.2008.132⟩
Molecular Therapy 8 (16), 1474-80. (2008)
Molecular Therapy, 2008, 16 (8), pp.1474-80. ⟨10.1038/mt.2008.132⟩
Molecular Therapy, Cell Press, 2008, 16 (8), pp.1474-80. ⟨10.1038/mt.2008.132⟩
Molecular Therapy 8 (16), 1474-80. (2008)
Liver tropism potentially leading to massive hepatocyte transduction and hepatotoxicity still represents a major drawback to adenovirus (Ad)-based gene therapy. We previously demonstrated that substitution of the hexon hypervariable region 5 (HVR5),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5031f121bc8db649ef4628eab0d0c1f
https://hal.science/hal-00315859
https://hal.science/hal-00315859
Autor:
Céline Bouquet, Didier Marot, Ivan Bièche, Frederique Kuttenn, Chantal Aumas, Michel Perricaudet, Sophie Vacher, Rosette Lidereau, Nicolas de Roux, Gwendal Lazennec, Stéphanie Esselin
Publikováno v:
Endocrine-Related Cancer
Endocrine-Related Cancer, BioScientifica, 2007, 14 (3), pp.691-702
Endocrine-Related Cancer, BioScientifica, 2007, 14 (3), pp.691-702. ⟨10.1677/ERC-07-0012⟩
Endocrine-Related Cancer, BioScientifica, 2007, 14 (3), pp.691-702
Endocrine-Related Cancer, BioScientifica, 2007, 14 (3), pp.691-702. ⟨10.1677/ERC-07-0012⟩
KiSS1 is a putative metastasis suppressor gene in melanoma and breast cancer-encoding kisspeptins, which are also described as neuroendocrine regulators of the gonadotropic axis. Negative as well as positive regulation of KiSS1 gene expression by est
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb90d9daafc05bdd04bf06174e751645
https://pubmed.ncbi.nlm.nih.gov/17914099
https://pubmed.ncbi.nlm.nih.gov/17914099
Autor:
Elisabeth Connault, Barbara Salone, Paule Opolon, Michel Perricaudet, Delphyne Descamps, Pierre Bobé, Stéphanie Esselin, Karim Benihoud, Isabella Saggio, Danielle Bonardelle, Betsy Jullienne
Publikováno v:
Gene Ther
Gene Ther, 2007, 14 (6), pp.551. ⟨10.1038/sj.gt.3302909⟩
Gene Therapy
Gene Therapy, Nature Publishing Group, 2007, 14 (6), pp.533-544. ⟨10.1038/sj.gt.3302885⟩
Gene Ther, 2007, 14 (6), pp.551. ⟨10.1038/sj.gt.3302909⟩
Gene Therapy
Gene Therapy, Nature Publishing Group, 2007, 14 (6), pp.533-544. ⟨10.1038/sj.gt.3302885⟩
International audience; The immunogenicity of recombinant adenoviruses (Ad) constitutes a major concern for their use in gene therapy. Antibody- and cell-mediated immune responses triggered by adenoviral vectors hamper long-term transgene expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d02adae38b0564567e86d0c0b0988bf
http://hdl.handle.net/20.500.12278/119636
http://hdl.handle.net/20.500.12278/119636
Autor:
Michel Perricaudet, Paule Opolon, Stéphanie Esselin, Delphyne Descamps, Karim Benihoud, Elisabeth Connault, Frédéric Vigant
Publikováno v:
Hepatology
Hepatology, Wiley-Blackwell, 2006, 44 (2), pp.314-7. ⟨10.1002/hep.21257⟩
Hepatology, Wiley-Blackwell, 2006, 44 (2), pp.314-7. ⟨10.1002/hep.21257⟩
International audience; Fas and tumor necrosis factor receptor 1 (TNFR1) are death receptors involved in various diseases such as hepatitis, sepsis, or graft rejection. Neutralizing antibodies to death ligands or soluble death receptors can inhibit c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0327df824c3427952d2cbb589e0c8a7d
https://hal.archives-ouvertes.fr/hal-00090520
https://hal.archives-ouvertes.fr/hal-00090520
Autor:
Delphyne Descamps, Frédéric Vigant, Paule Opolon, Elisabeth Connault, Karim Benihoud, Stéphanie Esselin, Michel Perricaudet
Publikováno v:
Molecular Therapy. 11:S202-S203
Top of pageAbstract Death receptors are involved in various diseases such as hepatitis, sepsis or graft rejection. Neutralizing antibodies against apoptotic ligands or soluble death receptors are currently used to inhibit apoptosis but side effects d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76c70d00dbc73f8b5b5dfd80170c011a
https://doi.org/10.1016/j.ymthe.2005.07.064
https://doi.org/10.1016/j.ymthe.2005.07.064
Autor:
Paule Opolon, Valeria Poli, Michel Perricaudet, Karim Benihoud, Isabella Saggio, Stéphanie Esselin, Barbara Salone, Monica Di Giovine
Publikováno v:
Scopus-Elsevier
Background The major concern for the use of adenoviral vectors for gene therapy is the viral-induced immune response that has been shown to be responsible for short-term transgene expression and inefficient viral readministration. In vivo studies and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::917d83115436fab5df44879e78586524
http://www.scopus.com/inward/record.url?eid=2-s2.0-0034184767&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0034184767&partnerID=MN8TOARS